Loxo Oncology competitors

Loxo Oncology Competitors include Keryx Biopharmaceuticals, NovaBay Pharmaceuticals, Chiasma and UCB.
Add company...
Loxo Oncology
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Chiasma
Chiasma
Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.
UCB
UCB
Patients are at the center of everything we do. At UCB, we are Inspired by patients. Driven by science.
Founding Date
Founding Date
2013
Founding Date
1998
Founding Date
2000
Founding Date
2001
Founding Date
1928
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Stamford, US HQ
South San Francisco, US
Locations
New York, US HQ
Boston, US
Locations
Emeryville, US HQ
Locations
Waltham, US HQ
Ness Ziona, IL
Locations
Anderlecht, BE HQ
Employees
Employees
4757% increase
Employees
1962% increase
Employees
21
Employees
166% decrease
Employees
7,5001% decrease
Valuation ($)
Valuation ($)
4.1 b
Valuation ($)
365.9 m
Valuation ($)
20 m
Valuation ($)
89.4 m
Valuation ($)
13.3 b
Twitter followers
Twitter followers
46
Twitter followers
391
Twitter followers
2.2 k
Twitter followers
42
Twitter followers
2.8 k

Financial

Net income
Net income
($148.9m) (FY, 2017)
Net income
($163.4m) (FY, 2017)
Net income
N/A
Net income
($26.8m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 57m
Total funding raised
N/A
Total funding raised
$ 13.6m
Total funding raised
$ 139.8m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Keryx Biopharmaceuticals
HQ
New York, US
Employees
196↑ 2% increase

Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases.

View company
NovaBay Pharmaceuticals
HQ
Emeryville, US
Employees
21

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

View company
Chiasma
HQ
Waltham, US
Employees
16↓ 6% decrease

Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.

View company
UCB
HQ
Anderlecht, BE
Employees
7,500↓ 1% decrease

Patients are at the center of everything we do. At UCB, we are Inspired by patients. Driven by science.

View company